Podcast: Play in new window | Download (Duration: 1:21:51 — 112.4MB) | Embed
Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Blubrry | Podcast Index | Email | TuneIn | RSS | More
Dr. Kelsey Moody is a process-oriented biotechnology executive who has specialized in the study of aging and aging mechanisms for over a decade. Since 2013, He has successfully built Ichor from a living room start-up into a premier, vertically integrated contract research organization that focuses on pre-clinical research services for aging pathways. Proceeds from this work are used to self-fund R&D initiatives that constitute Ichor’s portfolio companies in enzyme therapy (Lysoclear, Inc.), small molecule drug discovery (Antoxerene, Inc.), and protein engineering (RecombiPure, Inc.). Kelsey has received graduate-level training in medicine, business, and laboratory research.
Newsletter sign up (new and exciting developments)
Join this channel to get access to perks: https://www.youtube.com/channel/UCzri06unR-lMXbl6sqWP_-Q/join
Over 321 books from 170 plus interviews over 5 years
PODCAST INFO:
The Learning With Lowell show is a series for the everyday mammal. In this show we’ll learn about leadership, science, and people building their change into the world. The goal is to dig deeply into people who most of us wouldn’t normally ever get to hear. The Host of the show – Lowell Thompson- is a lifelong autodidact, serial problem solver, and founder of startups.
LINKS
Spotify: https://open.spotify.com/show/66eFLHQclKe5p3bMXsCTRH
RSS: https://www.learningwithlowell.com/feed/podcast/
Youtube: https://www.youtube.com/channel/UCzri06unR-lMXbl6sqWP_-Q
Youtube clips: https://www.youtube.com/channel/UC-B5x371AzTGgK-_q3U_KfA
Website: https://www.learningwithlowell.com/
Kelsey moody links
Timestamps /show notes
00:00 Intro
00:30 How are ichor life sciences not out of business
02:30 why don’t more people copy his business model
04:40 Finding the right investors
08:10 Sales in biotech
10:05 approach to hiring, managing, etc
11:20 Liquid liquid phase separation
16:00 Using phase separation
18:40 Protein vs Phase
22:24 Phase separation to find black swans
21:25 downside to phase separation
24:00 Phase separation being incorporated into portfolio / building tools.
27:11 Why choose phase separation / tool building
29:11 Future of ichor
30:10 Missing to meet that future
31:30 Build the headquarters / USA
33:33 Will they need $100 million
36:10 Startups / biotech wasting money
39:00 Continuity of vision / delusions / Moody in control
39:50 Getting the most from his team / biggest struggle
43:25 innovation days
45:30 Breakdown of startups in portfolio / interventions they’re developing FanQ
49:20 How far from clinical trials Fanq
51:18 Lipid Nano Particle to deliver your Lysoclear enzyme FANQ
54:24 Lysoclear enzyme compared to other interventions / macular degeneration
57:30 how will Lysoclear enzyme be applied elsewhere
59:30 Functional rejuvenation / aubrey de grey / repair future
01:02:30 Criticism Roche is leading these Ph2a trials / FanQ
01:07:18 Aubrey de grey LEV robust mouse rejuvenation study at ichor / insane!
01:10:50 Surprising / relieved developments from mouse rejuvenation study
01:12:18 building a ginkgo bioworks biobank
01:14:30 Surprising legal document
01:15:03 When was Kelsey happiest in life
01:16:07 Big sacrifice as a founder
01:18:50 Bryan johnson blueprint protocol / health optimization
01:20:33 Staying up to date.